| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention relates to medicine and pharmacology, namely to medications based on peptides. Composition includes 0.01-0.03 mg per one therapeutic dose of endogen interferon inductor - dipeptide of glutamic acid, selected from group, which includes alpha-glutamyl triptophan, gamma-glutamyl triptophan and alpha-lysyl glutamine, Composition also contains co-inductor of endogen interferon - glycyrrhizic acid, taken in form of sodium or ammonium salt in quantity 50-500 mg per one dose. ^ EFFECT: invention insures formation of prolonged antiviral resistance, necessary for fast and effective elimination of virus-causative agent and elimination of disease symptoms. ^ 3 cl, 1 tbl |
